Tetrasil, also known as Imusil, is a fake-AIDS cure that is
based on tetrasilver tetroxide, a chemical used to clean pool
water. Apparently, people are supposed to believe that because a
tiny amount of this highly dangerous chemical kills bacteria and
virii in swimming water, that a larger amount will kill infections
in humans. Of course, it is well known that it is poisonous to
drink rubbing alcohol. Not many people are familiar with
tetrasilver tetroxide. This is like saying that because you can
use rubbing alcohol to clean a cut or scrape, you should drink it
to kill a cold virus. This ‘cure’ is more likely to poison the
user than help fight the disease.

Of course, the marketers of Tetrasil, like most proponents of fake
cures, can’t have a single explanation for how their cure works.
Apparently the more extreme and outrageous the claims the better.
So, in addition to the ‘fact’ that tetrasilver tetroxide is used
in pool ‘proves’ that it is safe to ingest and will kill
infections, these tiny molecules are actually machines that
generate electricity and kill the AIDS virus, HIV, by zapping it
with electricity. (This claim is straight from the US patent for
Tetrasil, by the way. For those who don’t know – you can file a
patent for anything, including a time machine that will take you
to a non-existent universe. The patent office doesn’t care if the
thing works, just if you are copying someone else. So if you ever
see anyone waving around a patent as proof that their crazy claim
is valid – all it proves it no one else was crazy enough to want
to claim the idea.)

It is, however, very very interesting that the patent claims that
Tetrasil cures AIDS by electrocuting HIV, since the patent is held
by a ‘Dr’. Marvin S. Antelman, the maker of Tetrasil, who claims
that HIV has nothing to do with AIDS! Alright ‘Dr.’ Antelman, I’ll
give you the benefit of the doubt. Assuming that HIV has nothing
to do with AIDS, how do you cure a disease by killing something
that is totally unrelated to it?

You can’t. And you can’t cure AIDS without attacking HIV. Which is
just one more proof that the so-called doctor doesn’t know what he
is talking about and is just out to make a buck. Illogical claims
like this can be sold to people if the seller talks fast enough
and doesn’t give them time to stop and question the absurdity of
it, but a legitimate health professional wants people to ask
questions, wants to have problems pointed out so they can be
corrected. And a legitimate health worker does not make ridiculous
claims that directly contradict his OWN PATENT!

That isn’t the only difference between ‘Dr.’ Antelman and a
legitimate health worker. There are quite a few more. Among them,
a real researcher wants other people to test their findings, and
make sure their medicines work. This is called ‘third party
testing’. A researcher wants this for two reasons. First, someone
else doing the testing in a different way can make sure they
didn’t miss anything in their work. Second, it’s a promise to
their customers – ‘I have let my work be examined by other people,
who agree that it works and is safe.’ Apparently, ‘Dr.’ Antelman
feels neither of these are valid concerns, as the company he keep
proclaiming has tested Tetrasil and found it safe and effective,
is one that he owns. So basically he is saying ‘I have tested my
own invention and proved to myself that it is safe and will work –
and you can take my word for it!’

Worse, it isn’t safe, as Antelman’s own reported test results
prove. All but one of the people who took part in Antelman’s
‘clinical test’ of Tetrasil developed hepatomegaly or enlarged
livers. An enlarged liver only happens when a person has developed
a serious medical condition such as liver disease, congestive
heart failure or cancer! Of course, ‘Dr’. Antleman insists that
none of the test participants were harmed, and that an enlarged
liver is not dangerous. No, an enlarged liver doesn’t endanger a
person – but the problems that cause it DO! Of course, Antleman
couldn’t be bothered to test for further problems that might have
led his patients to develop hepatomegaly.

Yet this man, who wants us to take his word, has already
contradicted himself about how his so-called ‘cure’ works and
claims it is safe while publicly announcing that his test subjects
developed medical problems. It’s hard to trust someone who won’t
play straight, who contradicts himself, and is not open and
aboveboard.

At this time, Tetrasil is banned in Zambia because it has no
proven effects for people living with HIV. It is still legal to
sell in America (people need to be able to disinfect their pools)
but it is illegal to promote it as a treatment or preventative for
any disease.

In Zambia, the government has introduced a law to protect people
infected with the AIDS virus, HIV, from drugs that could harm
their health. The law will require all anti-AIDS medications
coming into the country to undergo clinical testing before being
sold on the local market. From Lusaka, Danstan Kaunda has the
story.

Many HIV patients in Zambia have abandoned life-prolonging
anti-retroviral drugs for what is said to be a miracle cure,
called ‘Tetrasil.’

Tetrasil appeared on the local market shortly after a Zambian
weekly newspaper published a story saying it can cure HIV with 21
days.

The tabloid quoted a controversial US-based California activist,
Boyd Graves, who said over 10 HIV patients have been disease-free
since January.

Graves has also said the U.S government manufactured the HIV virus
in a lab – a charge disputed by the mainstream scientific
community. According to the Atlanta-based Centers for Disease
Control, a team of international researchers reported in 1999 that
they had traced the origins of HIV-1, the predominant strain of
HIV in the developed world, to chimpanzees in west equatorial
Africa. The CDC's web page says, "The researchers believe that
HIV-1 was introduced into the human population when hunters became
exposed to infected blood." (www.cdc.gov/hiv/resources/qa/qa3.htm)

In response to the controversy over the alleged cure, the
government of Zambia has banned a local chemist – a sister company
to the tabloid that published the claims – from selling Tetrasil.
The government has also banned any press advertisements for it.

Under the new law, the Pharmaceutical Regulatory Authority of the
Ministry of Health will test the safety and efficacy of all drugs
and natural remedies, whether they are western medications or
locally available herbs.

Dr. Canisius Banda is a spokesperson in the Ministry of Health.

"A technical working group," he said, "will be put in place to
study these claims through scientific scrutiny, and if the drug
(Tetrasil) passes the tests, than we will find ways on how will it
be rolled out to the public, because it has to be an orderly
process. We are saying that about 1.6 million people in Zambia are
living with the HIV virus. Seventy-six thousand of them are on
ARVs (antiretrovirals), and about 200,000 need to be on them. So
if the process is not managed properly there could be a stampede
or chaos."

Banda said claims of a cure for HIV / AIDS are often false – and
hurt efforts to protect those infected – like government programs
to provide free anti-retrovirals to pregnant mothers.

"Derailing government programs is not a wise thing to encourage,"
he said, "because it can threaten national security, and again
that is a criminal activity. We will continue with the measures in
place, but also encourage people with these claims, so that they
are submitted to the ministry for scientific verification."

Meanwhile, the Network of Zambian People Living with HIV and AIDS
wants the government to arrest anyone found selling Tetrasil.

Zambia has one of Africa’s highest infection rates – with about 16
percent of its population of 11 million infected.

The often called silver peroxide and silver(II) oxide, AgO or
Ag2O2, is actually a mixed oxidation state silver(I,III) oxide. A
thermochemical cycle, with lattice energies calculated within the
"volume-based" thermodynamic approach, explain why the
silver(I,III) oxide is more stable than the hypothetical
silver(II) oxide. The coordination geometries of silver and copper
in their known oxides correlate with those associated to their
electron configurations in coordination compounds. The second
ionization energy is higher for Ag than for Cu, which can be
related to the small size of 3d orbitals and the resulting high
electron repulsion for the first transition series elements.

AIM: Venous ulcers are a common, chronic medical and social
problem. These ulcers are difficult to heal in most patients with
sustained venous hypertension. This pilot product evaluation
registry study has evaluated the efficacy and safety of an
antimicrobial silver oxide wound dressing ointment ("Silver Oxide
Ointment") as part of the treatment of 'difficult' venous
ulcerations.

METHODS: The study was conducted measuring the variations in the
area of the ulceration and microcirculatory parameters.

RESULTS: After four weeks, treatment with the Silver Oxide
Ointment proved more effective than the 'best management' used in
controls. Transcutaneous PO2 was increased (improved); Laser
Doppler skin flux and transcutaneous PCO2 were improved
(decreased). Also in the silver oxide group a significantly higher
number of venous ulcers were completely healed at four weeks. The
silver oxide ointment improved both the microcirculation and the
healing rate of their ulcers. No significant tolerability problems
were observed.

CONCLUSION: In difficult venous ulcerations, local treatment with
this Silver Oxide Ointment, as one component of the total wound
dressing, improved microcirculation measurements and healing rate.
Most of the treatments were done at home by the patients or by
their tutors. This study indicates the important role of this type
of treatment and indicates the need to plan larger and more
prolonged studies.

AIM: In addition to contemporary compression therapy, one of the
therapeutic approaches is the use of a topical wound care agent.
The goal of this pilot registry study is to evaluate the efficacy
and safety of a uniquely designed ointment containing multivalent
silver oxide (Ag4O4) in the healing of difficult diabetic or
venous ulcerations.

METHODS: Patients who had ulcers resulting from chronic venous
insufficiency or diabetes participated in this open-label,
randomized registry study. All patients were evaluated by
measuring both the area of the ulceration and microcirculatory
parameters. 148 patients were included in the study and
categorized into two main groups: venous ulcers and diabetic
ulcers. Each main group was then randomized into two sub-groups:
topical treatment with silver oxide ointment and the control group
(standard cleaning and compression management methods, without
silver ointment). All patients were treated with accepted cleaning
and compression management. RESULTS. In subjects with venous
ulcers: After 4 weeks, the silver treatment was more effective
than the control group treatment: Skin PO2 was increased 2.1 times
more than the control group (17.4% to 8.2%) and skin flux (RF) was
improved 1.6 times more than the control group (-38.7% to -24.2%).
The total surface area of the ulcer was significantly reduced in
the silver treatment group by 1.9 times the control group (-88.7%
to -46.9%). In addition, in the silver treatment group we observed
complete closure of the ulceration in 42% of subjects compared to
22% in the control group (P=<0.05). In subjects with diabetic
ulcers: after 4 weeks, the silver treatment was more effective
than the control group treatment: Skin PO2 increased 2.6 times
more than the control group (23.3% to 9.1%) and skin flux (RF) was
significantly improved 4.3 times more than the control
group(-26.7% to -6.2%). The total surface area of the ulcer was
significantly reduced in the silver treatment group by 3.7 times
the control group (-89.0% to -23.9%). In addition, in the silver
treatment group we observed complete closure of the ulceration in
39% of subjects compared to 16% in the control group
(P</=0.05).

CONCLUSION: This pilot study provides observational data on the
efficacy of local treatment of ulcers with a multivalent silver
oxide containing ointment. The silver ointment improved
microcirculation and the healing rate of all 78 patients that were
treated with multivalent silver ointment and closed twice as many
ulcers in 4 weeks compared to the control groups (40.7% silver
treatment compared to 19.4% for the control). This study
demonstrates the feasibility of this type of treatment and
provides evidence of efficacy to plan larger randomized controlled
studies. The large number of patients that were helped in this
study demonstrates the efficacy of multivalent silver oxide
topical ointment and its important role in ulcer therapy.

AIM: Venous ulcers are a common, chronic medical and social
problem. These ulcers are difficult to heal in most patients with
sustained venous hypertension. This pilot product evaluation
registry study has evaluated the efficacy and safety of an
antimicrobial silver oxide wound dressing ointment ("Silver Oxide
Ointment") as part of the treatment of 'difficult' venous
ulcerations.

METHODS: The study was conducted measuring the variations in the
area of the ulceration and microcirculatory parameters.

RESULTS: After four weeks, treatment with the Silver Oxide
Ointment proved more effective than the 'best management' used in
controls. Transcutaneous PO2 was increased (improved); Laser
Doppler skin flux and transcutaneous PCO2 were improved
(decreased). Also in the silver oxide group a significantly higher
number of venous ulcers were completely healed at four weeks. The
silver oxide ointment improved both the microcirculation and the
healing rate of their ulcers. No significant tolerability problems
were observed.

CONCLUSION: In difficult venous ulcerations, local treatment with
this Silver Oxide Ointment, as one component of the total wound
dressing, improved microcirculation measurements and healing rate.
Most of the treatments were done at home by the patients or by
their tutors. This study indicates the important role of this type
of treatment and indicates the need to plan larger and more
prolonged studies.

Antimicrobial effects of
TiO(2) and Ag(2)O nanoparticles against drug-resistant
bacteria and leishmania parasites.

Allahverdiyev AM1, Abamor ES, Bagirova M, Rafailovich M.

Abstract

Nanotechnology is the creation of functional materials, devices
and systems at atomic and molecular scales (1-100 nm), where
properties differ significantly from those at a larger scale. The
use of nanotechnology and nanomaterials in medical research is
growing rapidly. Recently, nanotechnologic developments in
microbiology have gained importance in the field of chemotherapy.
Bacterial strains that are resistant to current antibiotics have
become serious public health problems that raise the need to
develop new bactericidal materials. Metal oxide nanoparticles,
especially TiO(2) and Ag(2)O nanoparticles, have demonstrated
significant antibacterial activity. Therefore, it is thought that
this property of metal oxide nanoparticles could effectively be
used as a novel solution strategy. In this review, we focus on the
unique properties of nanoparticles, their mechanism of action as
antibacterial agents and recent studies in which the effects of
visible and UV-light induced TiO(2) and Ag(2)O nanoparticles on
drug-resistant bacteria have been documented. In addition, from to
previous results of our studies, antileishmanial effects of metal
oxide nanoparticles are also demonstrated, indicating that metal
oxide nanoparticles can also be effective against eukaryotic
infectious agents. Conversely, despite their significant potential
in antimicrobial applications, the toxicity of metal oxide
nanoparticles restricts their use in humans. However, recent
studies infer that metal oxide nanoparticles have considerable
potential to be the first-choice for antibacterial and
antiparasitic applications in the future, provided that
researchers can bring new ideas in order to cope with their main
problem of toxicity.

Tetrasil (Terrasil) attacks bacterial, viral, and fungal
infections like no other skin cream or ointment. It is highly
recommended to relieve itching, rashes, redness, burning and other
unwanted symptoms of skin infections. Customers say the result is
not just rapid relief of symptoms, but the entire elimination of
the root causes of these ailments.

Laboratory analysis, clinical studies, and patient feedback has
convinced Dr. Horowitz that Tetrasil's active ingredient,
Tetrasilver Tetroxide, interacts with the surfaces of bacterial,
fungal and viral membranes to help people heal better and faster
than any other product in its class.

Features & Ingredients

Upon contact, TETRASIL's unique chemical structure releases both a
micro-electrical charge and therapeutic oxygen, which immediately
begins to kill pathogens.
Dr. Horowitz expects this product, and advertisment, will be
attacked vigorously by the FDA simply because it works so well, at
such low cost, without any risks of toxicity when used correctly,
and without dangerous side effects presented by all pharmaceutical
antibiotics. (See instructions.)

Tetrasilver tetroxide - prepared at home. I prepared it from
AgNO3, NaOH and NaS2O8. I dissolved it in neutral organic solvent
and applied against my athletes feet twice and it worked-signs
disappeared.

Autism brains have DNA with
8 RNA viruses which may be inhibited by Tetrasilver
Tetroxide US PAT 6485755

Hello parents and family members of autistic children:

I have found some interesting information about the RNA viruses
associated with autism. RNA viruses for HIV and cancer are
inhibited by Tetrasilver Tetroxide US Pat 5676977 and US Pat
6485755 respectively.

These viruses were found in the brain DNA of 15 autistic children
in Italy who died by 2010 but had diagnoses of autism.
How did the JC virus from the US and the BK virus from the US
survive from 1971 until 2010 for 39 years? Tissue decomposes
when someone dies usually within 3 months in a moist climate {see
http://fac.utk.edu/}

Interestingly to note there were a total of FIVE herpes viruses
and two people viruses from patients who died in 1971 in the
US! Lastly Lintas found the AIDS or HIV virus from green
monkeys’ kidneys. This virus has been called the SV-40 virus
and first was named the SE Polyoma virus for Dr. Bernice Eddy,
PhD, and Dr Sarah Stewart, MD, PhD who found it in polio vaccine
complement used in the 1950s through 1963. They found that
the SE Polyoma virus could cause cancer in many animal species and
feared that it would cause cancer in humans.[2]

The BK virus was first isolated in 1971 from the urine of a renal
transplant patient, initials B.K.[3]The BK virus is similar to
another virus called the JCV since their genome sequences share
75% homology. [Essentially these viruses are very identical they
share 75% of the same genome sequences but BK and JC were not
related humans.] Polyomaviridae is the bkvirus family.
] Polyoma is the genus of the bkvirus and jcvirus. Both of
these viruses can be identified and differentiated from each other
by carrying out serological tests using specific antibodies or by
using a PCR based genotyping approach.

Who is JC of the jcvirus?

The jcvirus was from a patient with progressive multifocal
leukoencephalopathy (PML).[4]

Why are the animal and herpes RNA viruses mentioned in the work of
Carla Lintas so significant?
Where else are so many and varied animal viruses present to make
cells infected with Multiple Sclerosis? In the cell of a woman
patient with multiple sclerosis cultured in US PAT 6582703 See
Figure 45. A total of 18 different animal viruses were found in
the Multiple Sclerosis cell of an infected woman that were tissue
cultured for sale by Perron and Jean Marie Seigneurin co-holders
of US Patent 6582703 In FIGURE 45 RNA Viruses from Asian Indian
Gibbon Ape, West African Green Monkey, South African Baboon,
Chimp, Central/South American Squirrel Monkey, Icelandic Sheep
Nazi Maedi VISNA virus, Cow Lymphoma, Horse Leukemia, + Simian
Foamy Virus etc. are mentioned.

The present invention discloses a tetrasilver tetroxide fungicide,
a preparing method and an application thereof. The tetrasilver
tetroxide fungicide comprises the following components by weight
part: weak alkaline solution 800-1200 parts, tetrasilver tetroxide
0.1-0.5 parts, and polyvinyl alcohol 8-20 parts. The preparing
method of the tetrasilver tetroxide fungicide comprises the
following steps: using the weak alkaline solution with pH value of
7.0-7.5 as dissolvent, fetching 800-1200 parts of weak alkaline
solution, and adding 0.1-0.5 parts of tetrasilver tetroxide,
sufficiently diluting and uniformly mixing 8-20 parts of polyvinyl
alcohol with the obtained solution in which the polyvinyl alcohol
is used as carrier, and then the tetrasilver tetroxide fungicide
is prepared. The invention also discloses the application of the
tetrasilver tetroxide fungicide as a disinfection additive. The
preparing method of the tetrasilver tetroxide fungicide according
to the invention is simple and is suitable for large-scale
production.

Technical field

The present invention relates to a four silver oxide bactericide,
its preparation and application.

Background technique

At present, the research and application of bactericides mainly
focus on the medicaments for preventing and curing the diseases
caused by fungi, and the research and development of medicaments
for preventing and curing diseases caused by bacteria and viruses
is not enough. Silver bactericidal effect has long been found in
recent years, people in the process of sterilizing silver
sterilization, but also gradually want to apply the principle of
sterilizing silver products to go, but the market has not yet as a
bactericide to prevent bacteria and viruses , And the example
applied to the product appears. In the July 2005 issue of "Chinese
Journal of New Drugs and Clinical Medicine", "Progress in the
research of medicinal silver tetraoxide" was reported, indicating
that it is expected to become a novel antimicrobial agent and be
used in the treatment of AIDS, cancer and other diseases .

Content of the invention

Object of the Invention: The purpose of the present invention is
to provide a four-silver tetrabasic bactericide prepared from
tetra-silver tetraoxide, a preparation method thereof and its use
as a bactericidal additive.

Technical solution: a silver tetrabasic fungicide, which comprises
the following components in weight: 800 to 1200 parts of weak
alkaline solution, 0.1 to 0.5 parts of silver tetraoxide, and 8 to
20 parts of polyvinyl alcohol.

Four silver tetrafluoroborate bactericide includes the following
components by weight: 1000 parts of weak alkaline solution, 0.2
parts of silver tetraoxide, and 10-15 parts of polyvinyl alcohol.

Preparation of tetrabasic silver fungicides, which comprises the
following steps:

Application of Four Silver Oxide Bactericide as Antibacterial
Additive in Antibacterial Plastic Products.
Application of Four Silver Tetraoxide Bactericide as Antibacterial
Additive in Antibacterial Fiber Products.
Application of Four Silver Oxide Bactericide as Antibacterial
Additive in Antibacterial Fabric.
Application of Tetraoxysilver Antibiotics as Bactericidal
Additives to Plant Diseases Caused by Microbes of Various
Pathogens.
Application of Four Silver Oxide Bactericide as Antibacterial
Additive in Antibacterial Coatings.

According to two kinds of fungicide mechanism of action: ① by
interfering with the respiratory process of germs, inhibit the
production of energy to kill bacteria. ② interfere with microbial
life substances such as proteins, nucleic acids, alcohols and
other biosynthesis to kill bacteria. Tetraoxide silver tetraoxide
prepared four silver fungicides as fungicides belong to the second
type of mechanism of action. The mechanism of Ag4O4 was analyzed.
The antibacterial order of Ag4O4 was: Ag <3 +> Ag <2
+> Ag <1+>, and Ag4O4 was a kind of Ag4O4 with A unique
conformation of "multivalent silver" oxide that redox reactions
with exposed 2N and 2S groups on the protein surface produces
electrical kill and chelation that result in altered protein
conformation. Its mechanism of action is different from the
general antimicrobial agents, the mode of action is not easy to
cause the pathogen resistance or mutation, no toxicity to normal
tissues, with anti-microbial and anti-inflammatory cells.

Beneficial effects: Four silver tetraoxide interferes with the
function of preventing biosynthesis of bacterial cells, especially
bacteria and viruses, and antimicrobial plastic products,
antimicrobial fiber products, antibacterial fabrics , Against
various pathogenic microorganisms caused by plant diseases,
medical equipment and reagent additives, antibacterial coatings
and antibacterial ware widely used in these fields, with good
inhibition of bacteria, viruses, the preparation method of the
present invention is simple, suitable for large Scale industrial
production, application method is simple and practical.

Detailed description

The present invention will be further described below in
combination with specific embodiments.

The reagent containing the silver tetrafluoroborate obtained in
Example 1 was sprayed on the air filter element to naturally cure
and dry the air filter element with antibacterial effect.
Tetraoxide silver fungicide can also be added in the form of
plastic coupling agent, about to dissolve the solution of tetrad
silver anti-bacterial agent sprayed on the plastic particles, and
then dried to use.

After testing, spray sterilized four four silver oxide
air-conditioning filter in Escherichia coli, Staphylococcus
aureus, Klebsiella pneumoniae, Aerobacter aerogenes, Campylobacter
brevis, the survival rate of mixed strains were 0 , Which shows
that four silver antimicrobial agent has the role of killing
bacteria and mold.

The tetracycline antimicrobial agent obtained in Example 1 was
directly combined with the air conditioning case in the form of a
mist or coating on the formed air conditioning case. Because the
exterior of the air conditioning is very smooth, you can use
corona treatment, that is, under the action of high voltage
electric field, the electron current exerts a powerful impact on
the surface of the air conditioning enclosure, which can make the
surface of the enclosure furred, roughened and increase the
surface area. When in contact with its surface, it will create a
good wetting that will penetrate into the furrows that have been
pulled, and will be firmly anchored to the plastic shell by
anchoring. Use this principle, the corona treatment will be four
silver tetrachloride bactericide spray applied or coated by the
temperature of 60 ~ 80 ° C for 8 to 12 minutes to dry, so that the
four silver tetrachloride bactericide by complexation Fixed on the
plastic shell surface.

After testing, spraying four tetra-antimicrobial tetracycline in
the air-conditioned housing Escherichia coli, Staphylococcus
aureus, Klebsiella pneumoniae, Aerobacter aerogenes, Bacillus
crillium, species mixed survival rate was 0 , Which shows that
four silver antimicrobial agent has the role of killing bacteria
and mold.
Example 4: Preparation of tetrad silver oxide bactericide.

After testing, coated silver tetrabuicides disinfectant PP drawing
grade fiber products Escherichia coli, Staphylococcus aureus,
Klebsiella pneumoniae, Aerobacter aerogenes, Campylobacter sp., A
mixture of strains Survival rate is 0, we can see that four silver
tetrabasic fungicides have the role of killing bacteria and mold.

Example 6: Use of Tetraoxysilver Antibiotics as Antibacterial
Additives in Antibacterial Fiber Products.

The tetrad silver oxide bactericide obtained in Example 4 is added
to the hot melt adhesive, and the child with a bactericidal effect
can be made to be wet by the coating method.

After testing, children coated with silver tetrasulfate
antimicrobial agents used in diabetics, Staphylococcus aureus,
Klebsiella pneumoniae, Aerobacter aerogenes, Campylobacter
crispus, bacteria mixed kind of survival The rate is 0, we can see
that four silver tetrabasic fungicides have the role of killing
bacteria and mold.

Example 7: Use of Tetraoxysilver Antibiotics as Antibacterial
Additives in Antibacterial Fiber Products.

The tetrafluoroborate antimicrobial agent obtained in Example 4
was added to the hot melt adhesive, and the sanitary napkin and
the panty liner with bactericidal effect were prepared by the
coating method.

After testing, coated with four silver tetrasulfide disinfectant
sanitary napkins, sanitary pads in Escherichia coli,
Staphylococcus aureus, Klebsiella pneumoniae, Aerobacter
aerogenes, Bacillus crillium, mixed species Survival rate is 0, we
can see that four silver tetrabasic fungicides have the role of
killing bacteria and mold.

Example 8: Use of a silver tetraborate antimicrobial agent as
an antimicrobial additive in an antimicrobial fabric.

The medical staff and patient clothing were immersed in the
solution of the silver tetrabasic fungicide prepared in Example 4,
and the antibacterial effect of medical staff and patient clothing
were obtained by centrifuging and recovering the solution, drying
and drying.

After testing, infiltration of tetrabenzene antimicrobial
tetracycline antibacterial agents and patient clothing Escherichia
coli, Staphylococcus aureus, Klebsiella pneumoniae, Aerobacter
aerogenes, Campylobacter brevis, the survival rate of mixed
species Are 0, we can see that four silver tetrabasic fungicides
have the role of killing bacteria and mold.

Example 9: Use of Tetraoxysilver Antibiotics as Antibacterial
Additives in Antibacterial Fabrics.

The wound paste was immersed in a solution of the silver
tetraborate antimicrobial agent obtained in Example 4, and the
wound paste with antibacterial effect was obtained by centrifugal
dehydration recovery solution, drying and drying.

After testing, infiltrated four antimicrobial silver tetrazolium
agents in the wound paste E. coli, Staphylococcus aureus,
Klebsiella pneumoniae, Aerobacter aerogenes, Campylobacter brevis,
the survival rate of mixed strains were 0 , Which shows that four
silver antimicrobial agent has the role of killing bacteria and
mold.

When watering wheat, the silver tetrabasic bactericide prepared in
Example 10 can be diluted at a concentration of 10 to 30 ppb, and
diseases caused by various pathogenic microorganisms can be
effectively prevented by spraying or pouring.

After testing, pouring over the water containing four tetrabasic
silver disinfectant of wheat, Escherichia coli, Staphylococcus
aureus, Klebsiella pneumoniae, Aerobacter aerogenes, Campylobacter
crispus, the survival rate of mixed strains Are 0, we can see four
silver oxide bactericide has the effect of killing bacteria and
fungi, thereby effectively inhibiting the pathogenic
microorganisms caused by the disease.

The silver tetraborate antimicrobial agent prepared in Example 10
was diluted to a concentration of 10 to 30 ppb and sprinkled onto
apple trees by spraying or pouring to effectively prevent apple
tree diseases caused by various pathogenic microorganisms.

After testing, poured over the water containing four tetrasulfan
antimicrobial apple trees, Escherichia coli, Staphylococcus
aureus, Klebsiella pneumoniae, Aerobacter aerogenes, Campylobacter
crispus bacteria, mixed species of survival The rate is 0, we can
see that four silver tetrabasic fungicides have the role of
killing bacteria and fungi, which effectively inhibit the disease
caused by pathogenic microorganisms.

Example 13: Use of Tetraoxide Tetraoxide Bactericide in Plant
Diseases Against Various Pathogenic Microorganisms.

The silver tetraborate antimicrobial agent obtained in Example 10
was diluted to a concentration of 10 to 30 ppb and sprinkled onto
the lawn by spraying or pouring to effectively prevent the lawn
disease caused by various pathogenic microorganisms.

After testing, after pouring water containing tetra-oxystericum
water after the lawn, Escherichia coli, Staphylococcus aureus,
Klebsiella pneumoniae, Aerobacter aerogenes, Campylobacter sp.,
The survival rate of mixed species Are 0, we can see four silver
oxide bactericide has the effect of killing bacteria and fungi,
thereby effectively inhibiting the pathogenic microorganisms
caused by the disease.

Example 14: Use of Tetraoxysilver Antibiotics as Antibacterial
Additives in Antibacterial Coatings.

The silver tetraborate antimicrobial agent obtained in Example 10
was added to the paint and paint at a concentration of 10 to 50
ppm, and the paint or paint was sprayed on handrails, computers,
telephones, toys, wood floors and the like frequently. More
bacteria were used Of the items, so that spray paint, paint items
with antibacterial effect.

SILVERQUINE Animal Wound Dressing is a water-base hydro gel wound
dressing for use in moist wound care management. The gel contains
silver that may help inhibit the growth of microorganisms within
the dressing. SILVERQUINE Animal Wound Dressing Gel has been
evaluated in standard tests that show it can reduce the level of
common microorganisms.

It has been known for over a century that certain preparations of
silver have germicidal properties. As a result, prior to the
invention of modern day antibiotics, silver was used to help treat
wounds and other types of infections in animals. With the
development of natural antibiotics, silver preparations were
phased out in favor of synthetic antibiotics. Unfortunately, over
the course of the past 25 years, multiple bacteria have developed
resistance to common antibiotics on the market today. In some
circumstances, prolonged courses of expensive antibiotics have to
be used to get a minimal response and expose your pet to potent
side effects. Worse yet, some antibiotics are totally ineffective
in some cases. As a result, the pet industry is in urgent need of
new technology that has broad spectrum antimicrobial activity to
reduce wound healing times and reduce the risk of side effects
from current treatments.

Silverquine Animal Wound Dressing is a new, unique,
nano-particulate based silver that is very different from the
synthetic antibiotics used for the past 80 years in the animal
arena. Our technology is ALL NATURAL and contains no alcohol or
synthetic chemicals that inhibit stem cell activity or
epithelization. In addition, the silver in our animal wound
dressing gel is not just another silver. Silverquine Animal Wound
Dressing consists of silver nanomolecules (less than .015
micrometers in size) with an interior metallic silver and an
exterior of ionic silver suspended within a water molecule.

The ingredients in Silverquine Animal Wound Dressing Gel are all
natural. In addition to the patented, unique, nano-particles of
silver, the product also contains purified water, TEA, and
carbomer. TEA (triethanolamine) and carbomer are organic products
that are mixed together in very low concentrations to form a gel.
Our Silverquine Gel product contains these two ingredients in
minute concentrations for a gelling effect. Both of these
ingredients are commonly used in cosmetic products for animals and
are considered very safe.

Safety

The key antimicrobial agent in Silverquine Animal Wound Dressing
Gel is the patented silver nanoparticles. For the past 15 years,
there has been a significant push to use the lowest possible dose
effective to treat an infection. Lower doses typically result in
fewer side effects. For example, one of the most common topical
therapies currently used in the pet industry is silver
sulfadiazine cream. That product contains 10,000ppm of silver.
Such high concentrations often time leads to wound maceration and
the need for debridement of some skin around the infected wound
area. Such high concentrations can have a negative impact on stem
cell activity and epithelization (new skin growth and wound
closing) resulting in slower wound healing. Ironically, our
products containing Silverquine Animal Wound Dressing Gel contains
less than 100ppm of silver, does not negatively impact stem cell
activity and epithelization, and promotes effective wound healing.

Silverquine Animal Wound Dressing Gel has been studied in a series
of safety studies including animals. These safety and toxicology
studies have demonstrated safe, beneficial, and non-toxic data.